Credit: NIH
The virus surface (yellow) is covered with proteins called hemagglutinin (blue) and neuraminidase (red).
Influenza vaccines that better target the influenza surface protein called neuraminidase (NA) could offer broad protection against various influenza virus strains and lessen the severity of illness, according to new research published in Cell.
Current seasonal influenza vaccines mainly target a different, more abundant influenza surface protein called hemagglutinin (HA). However, because influenza vaccines offer varying and sometimes limited protection, scientists are exploring ways to improve vaccine effectiveness. The new research builds on previous studies of NA and was conducted by a team of scientists including investigators from the Centers of Excellence for Influenza Research and Surveillance (CEIRS)program, which is organized and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Investigators analyzed blood samples from people vaccinated against influenza and people diagnosed with either the 2009 H1N1 influenza virus or H3N2 influenza viruses. The volunteers were recruited for this study or had taken part in prior influenza research studies. The analyses indicate that influenza vaccines rarely induce NA-reactive antibodies, whereas natural influenza infection induces these types of antibodies at least as often as they induce HA-reactive antibodies. Additional studies in mice reinforced the human data, indicating that current influenza vaccines do not induce NA-reactive antibodies efficiently.
Additional laboratory experiments show that the NA-reactive antibodies induced during natural influenza infection are broadly reactive, meaning they could potentially protect against diverse strains of influenza. To test this theory, scientists isolated NA-reactive monoclonal antibodies from the H3N2 and H1N1 influenza patients (N2-reactive antibodies and N1-reactive antibodies, respectively). They administered 13 N2-reactive antibodies to mice and subsequently infected the mice with a different H3N2 virus strain. Eleven of the 13 N2-reactive antibodies partially or fully protected the mice. They also administered eight N1-reactive antibodies to mice and subsequently infected the mice with a similar H1N1 virus strain or an H5N1-like virus strain. Four of the eight antibodies completely protected the mice against both virus strains.
The authors note that the findings suggest that influenza vaccines should be optimized to better target NA for broad protection against diverse influenza strains. In this regard, NIAID is supporting research to characterize NA responses in infected and vaccinated individuals and to determine the mechanism of action of NA protection. NIAID also supports “NAction!” a CEIRS working group that identifies knowledge gaps in our understanding of NA and sets NA research priorities for improved influenza vaccines. These efforts contribute to NIAID’s larger plan to develop a universal influenza vaccine—a vaccine that can durably protect all age groups against multiple influenza virus strains.
Learn more: Research Offers Clues for Improved Influenza Vaccine Design
The Latest on: Influenza
via Google News
The Latest on: Influenza
- Two more Deschutes County backyard bird flocks found to have avian influenza, for total of 6; about 150 birds euthanizedon August 2, 2022 at 11:49 am
Two more large non-commercial backyard flocks of birds in Deschutes County have been euthanized after they were confirmed to have highly pathogenic avian influenza (HPAI), bringing the total in the ...
- Study aims to assess the accuracy of influenza rapid diagnostic testson August 2, 2022 at 6:52 am
Increasingly, laboratory testing for influenza has shifted to in-clinic testing using point-of-care (POC) devices. Rapid diagnostic tests are a class of POC tests that can be performed with a few ...
- Surges in influenza-like illness may herald next pandemicon August 1, 2022 at 11:15 pm
The group studied whether there were spikes in respiratory illnesses which were not influenza before the first COVID-19 cases were positively identified.
- Avian influenza poses threat to wild, domestic birds across the countryon August 1, 2022 at 5:44 pm
Since February, wild birds in all four major migration areas of North America have been infected with Avian influenza. According to the CDC, it's been detected in two northern California counties.
- Canine influenza spreading rapidly across Alabamaon August 1, 2022 at 7:38 am
Canine Influenza is rapidly spreading across the country and has significantly impacted Alabama for the first time.
- What is the role of vitamin D in pandemic H1N1 influenza and SARS-CoV-2 infection?on August 1, 2022 at 4:37 am
Low vitamin D levels have been associated with poor outcomes following respiratory diseases such as influenza. High-dose vitamin D supplements have been suggested to decrease seasonal flu severity.
- Avian Influenza case confirmed in Flathead Countyon July 30, 2022 at 7:50 am
State officials report that Highly Pathogenic Avian Influenza (HPAI) has been confirmed in a Flathead County backyard poultry flock.
- Canine influenza cases on the rise in Birminghamon July 29, 2022 at 7:01 am
With canine influenza cases on the rise in Birmingham, Dr. Andy Sokol with the Caldwell Mill Animal Clinic joined the CBS 42 Morning News to discuss how to protect your pet.
- Avian influenza: the need to apply experienceon July 28, 2022 at 4:25 am
A subtype H5N6 was first reported in people in 2014 there have been 81 confirmed human cases resulting in 33 deaths. Of these 81 cases, 55 (68%) have occurred in 2021–22, mostly in China. These ...
via Bing News